A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
Clinical trial NCT03432260 · COMPLETED
Trial details
- NCT number
- NCT03432260
- Sponsor
- Durect
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2019-09-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.